| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Asprosin|Fibrillin-1|FBN1|FBN1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human Asprosin (FBN1) is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of Asprosin is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Asprosin can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Asprosin (FBN1) may also be referenced as Asprosin, Fibrillin-1, and FBN1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Asprosin relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in Asprosin levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Asprosin has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Asprosin‐FABP5 Interaction Modulates Mitochondrial Fatty Acid Oxidation through PPARα Contributing to MASLD Development
IF: 14.3 Journal: Advanced Science Author: Department of Pharmacology, SKLFZCD, (State Key Laboratory -Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, 150081, Cited Date: 2025-04-25
Circulating asprosin concentrations in individuals with new-onset type 2 diabetes and prediabetes
IF: 5.1 Journal: Diabetes Research and Clinical Practice Author: Department of Endocrinology, Jinan Central Hospital, Shandong University, Jinan, China. Cited Date: 2024-06-14
Serum Asprosin Correlates with Indirect Insulin Resistance Indices
IF: 4.757 Journal: Biomedicines Author: Department of Public Health, Poznan University of Medical Sciences, Rokietnicka St. 4, 60-806 Poznań, Poland Cited Date: 2023-06-02
Isthmin 1, matrix metalloproteinase 8 and asprosin as potential biomarkers in periodontitis with obesity
IF: 3.1 Journal: BMC Oral Health Author: Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, 98 Xiwu Road, Xi'an, Shaanxi Province, 710004, China. Cited Date: 2025-10-17
Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
IF: 2.1 Journal: Medical Science Monitor Author: Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey. Cited Date: 2025-10-17
Association between asprosin and metabolic syndrome in people living with human immunodeficiency virus: A case–control study
IF: 1.4 Journal: Medicine Author: Department of Infection, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, China Cited Date: 2025-10-24
Post-ERCP Pancreatitis and Serum Asprosin: A Potential Marker Associated with Beta Cell Damage
IF: Journal: Journal of Ankara University Faculty of Medicine Author: Department of Internal Medicine, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, 06800, Türkiye Cited Date: 2025-10-17